Brazil’s New Anti-Bribery Law Has Consequences for Industry, Experts Warn

International Medical Device Regulatory Monitor
A A
Devicemakers that operate in Brazil should be checking to see that none of their business holdings has been charged with corrupt practices — either in Brazil or elsewhere in the world, experts warned during a recent American Bar Association meeting devoted to the country’s new antibribery law.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $40.00